Methylenetetrahydrofolate Reductase C677T Polymorphisms as a Risk Factor for Polycystic Ovarian Syndrome in a Sample of Jordanian Women

Autor: Ghoul I, Alrawashdeh Hm, Azzam Oa, Samir Mahgoub, Al-Kharabsheh Am, Abd El kareem Hm, Ramadan Bk, Farhan Ss

Publikováno v: La Prensa Medica Argentina. 106

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3b00f283b9cf35f0a4daf0e13a7e2cd0
https://doi.org/10.47275/0032-745x-213

Lymphotoxin beta-activated LTBR/NIK/RELB axis drives proliferation in cholangiocarcinoma.

Autor: Xu K; Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.; Liver Cancer Center Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.; Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Kessler A; Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.; Liver Cancer Center Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.; Department of Medicine A, Hematology, Oncology, Hemostaseology and Pneumology, University Hospital Münster, Münster, Germany., Nichetti F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Computational Oncology, Molecular Diagnostics Program, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Hoffmeister-Wittmann P; Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.; Liver Cancer Center Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.; Department of RadioOncology and Radiation Therapy, Heidelberg University Hospital, Heidelberg, Germany., Scherr AL; Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.; Liver Cancer Center Heidelberg, Heidelberg University Hospital, Heidelberg, Germany., Nader L; Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.; Liver Cancer Center Heidelberg, Heidelberg University Hospital, Heidelberg, Germany., Kelmendi E; Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.; Liver Cancer Center Heidelberg, Heidelberg University Hospital, Heidelberg, Germany., Schmitt N; Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.; Liver Cancer Center Heidelberg, Heidelberg University Hospital, Heidelberg, Germany., Schwab M; Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.; Liver Cancer Center Heidelberg, Heidelberg University Hospital, Heidelberg, Germany., García-Beccaria M; Division of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), Heidelberg, Germany.; Madrid Institute for Advanced Study (MIAS), Madrid, Spain., Sobol B; Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.; Department of Gynecology and Obstetrics, University of Heidelberg, Heidelberg, Germany., Nieto OA; Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.; Department of Gynecology and Obstetrics, University of Heidelberg, Heidelberg, Germany., Isele H; Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.; Liver Cancer Center Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.; Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Gärtner U; Interfaculty Biomedical Research Facility, University of Heidelberg, Heidelberg, Germany., Vaquero-Siguero N; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Cancer Progression and Metastasis Group, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Volk J; Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Cancer Progression and Metastasis Group, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany., Korell F; German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Mock A; Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Institute for Pathology, Medical Faculty, Ludwig-Maximilians-University, Munich, Germany., Heide D; Division of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), Heidelberg, Germany., Ramadori P; Division of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), Heidelberg, Germany., Lenoir B; Clinical Cooperation Unit Applied Tumor Immunity, German Cancer Research Center, Heidelberg, Germany., Albrecht T; Liver Cancer Center Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.; Medical Faculty, Institute for Pathology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany., Hüllein J; Computational Oncology, Molecular Diagnostics Program, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Jäger D; Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.; Liver Cancer Center Heidelberg, Heidelberg University Hospital, Heidelberg, Germany., Fröhling S; German Cancer Consortium (DKTK), Heidelberg, Germany.; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany., Springfeld C; Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.; Liver Cancer Center Heidelberg, Heidelberg University Hospital, Heidelberg, Germany., Jackstadt R; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Cancer Progression and Metastasis Group, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany., Heikenwälder M; Division of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), Heidelberg, Germany.; The M3 Research Center, Medical Faculty, University Clinic Tübingen (UKT), Tübingen, Germany., Dill MT; Liver Cancer Center Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.; Department of Gastroenterology, Infectious Diseases and Intoxication, Heidelberg University Hospital, Heidelberg, Germany.; Research Group Experimental Hepatology, Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Roessler S; Liver Cancer Center Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.; Medical Faculty, Institute for Pathology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany., Goeppert B; Institute of Pathology, RKH Klinikum Ludwigsburg, Ludwigsburg, Germany.; Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland., Köhler BC; Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.; Liver Cancer Center Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.

Publikováno v: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2024 Nov; Vol. 44 (11), pp. 2950-2963. Date of Electronic Publication: 2024 Aug 20.

Assessment of PD-1 and PD-L1 tissue expression levels in lichen planus patients: a case-control study.

Autor: Elmasry MF; Dermatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt. mahafathy1214@cu.edu.eg., Mosaad RA; Dermatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt., Azzam OA; Dermatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt., Rashed LA; Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Cairo University, Cairo, Egypt., Fahim A; Dermatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.

Publikováno v: Archives of dermatological research [Arch Dermatol Res] 2024 Mar 02; Vol. 316 (3), pp. 97. Date of Electronic Publication: 2024 Mar 02.

Impact of Adjuvant Radiotherapy in Patients with Central Neurocytoma: A Multicentric International Analysis.

Autor: Samhouri L; Department of Radiation Oncology, University Hospital Münster, Münster 48149, Germany., Meheissen MAM; Alexandria Clinical Oncology Department, Alexandria University, Alexandria 21500, Egypt.; Specialized Universal Network of Oncology (SUN), Alexandria 21500, Egypt., Ibrahimi AKH; Department of Radiotherapy and Radiation Oncology, King Hussein Cancer Center, Amman 11942, Jordan., Al-Mousa A; Department of Radiotherapy and Radiation Oncology, King Hussein Cancer Center, Amman 11942, Jordan., Zeineddin M; Department of Pediatrics, King Hussein Cancer Center, Amman 11942, Jordan., Elkerm Y; Specialized Universal Network of Oncology (SUN), Alexandria 21500, Egypt.; Cancer Management and Research Department, Medical Research Institute, Alexandria University, Alexandria 21500, Egypt., Hassanein ZMA; Alexandria Clinical Oncology Department, Alexandria University, Alexandria 21500, Egypt.; Specialized Universal Network of Oncology (SUN), Alexandria 21500, Egypt., Ismail AA; Alexandria Clinical Oncology Department, Alexandria University, Alexandria 21500, Egypt.; Specialized Universal Network of Oncology (SUN), Alexandria 21500, Egypt., Elmansy H; Specialized Universal Network of Oncology (SUN), Alexandria 21500, Egypt.; Cancer Management and Research Department, Medical Research Institute, Alexandria University, Alexandria 21500, Egypt., Al-Hanaqta MM; Military Oncology Center, Royal Medical Services, Amman 11942, Jordan., Al-Azzam OA; Princess Iman Research Center, King Hussein Medical Center, Royal Medical Services, Amman 11942, Jordan., Elsaid AA; Alexandria Clinical Oncology Department, Alexandria University, Alexandria 21500, Egypt.; Specialized Universal Network of Oncology (SUN), Alexandria 21500, Egypt., Kittel C; Department of Radiation Oncology, University Hospital Münster, Münster 48149, Germany., Micke O; Department of Radiotherapy and Radiation Oncology, Franziskus Hospital Bielefeld, 33699 Bielefeld, Germany., Stummer W; Department of Neurosurgery, University Hospital Münster, 48149 Münster, Germany., Elsayad K; Department of Radiation Oncology, University Hospital Münster, Münster 48149, Germany., Eich HT; Department of Radiation Oncology, University Hospital Münster, Münster 48149, Germany.

Publikováno v: Cancers [Cancers (Basel)] 2021 Aug 26; Vol. 13 (17). Date of Electronic Publication: 2021 Aug 26.

Mapping innovation trajectories on SARS-CoV-2 and its variants.

Autor: Jefferson OA; Cambia, Canberra, Australian Capital Territory, Australia. osmat@cambia.org., Koellhofer D; Cambia, Canberra, Australian Capital Territory, Australia., Warren B; Cambia, Canberra, Australian Capital Territory, Australia., Ehrich T; Cambia, Canberra, Australian Capital Territory, Australia., Lang S; Cambia, Canberra, Australian Capital Territory, Australia., Williams K; Cambia, Canberra, Australian Capital Territory, Australia., Ballagh A; Cambia, Canberra, Australian Capital Territory, Australia., Schellberg B; Cambia, Canberra, Australian Capital Territory, Australia., Sharma R; Cambia, Canberra, Australian Capital Territory, Australia., Jefferson RA; Cambia, Canberra, Australian Capital Territory, Australia.

Publikováno v: Nature biotechnology [Nat Biotechnol] 2021 Apr; Vol. 39 (4), pp. 401-403.